Veru
VERU
#9942
Rank
โ‚ฌ31 M
Marketcap
1,93ย โ‚ฌ
Share price
6.07%
Change (1 day)
-69.48%
Change (1 year)

P/E ratio for Veru (VERU)

P/E ratio as of January 2026 (TTM): -0.9277

According to Veru's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.92766. At the end of 2022 the company had a P/E ratio of -3.69.

P/E ratio history for Veru from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2022-3.69-87.46%
2021-29.5-106.81%
2020433-2682.09%
2019-16.8366.61%
2018-3.59
2016-11.6-235.43%
20158.53

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Onconova Therapeutics
ONTX
-0.9953 7.29%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-5.38 479.41%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.